Worldwide Healthcare Trust plc (WWH) ORD GBP0.025

Sell:357.50pBuy:358.00p0.50p (0.14%)

FTSE 250:0.08%
Market closed |
Prices delayed by at least 15 minutes
Sell:357.50p
Buy:358.00p
Change:0.50p (0.14%)
Market closed |
Prices delayed by at least 15 minutes
Sell:357.50p
Buy:358.00p
Change:0.50p (0.14%)
Market closed |
Prices delayed by at least 15 minutes

Trust Information

About this company

Worldwide Healthcare Trust PLC is a specialist investment trust. It invests in the global healthcare sector with the objective of achieving a high level of capital growth. It invests worldwide in a diversified portfolio of shares in pharmaceutical and biotechnology companies and related securities in the healthcare sector. It will not invest more than 15% of the portfolio in any one individual stock at the time of acquisition. It invests over 50% of the portfolio in larger companies, and 20% of the portfolio in smaller companies. It may invest 5% of the portfolio, at the time of acquisition, in debt instruments, convertibles and royalty bonds issued by pharmaceutical and biotechnology companies. It may invest 40% of the portfolio in companies in the healthcare equipment and supplies sector and 30% of the portfolio in companies in the healthcare providers and services sector. Its alternative investment fund manager is Frostrow Capital LLP. OrbiMed Capital LLC is its portfolio manager.

Objective

In order to achieve a high level of capital growth, the Company invests in the global healthcare sector and in a diversified portfolio of shares in pharmaceutical and biotechnology companies and related securities in the healthcare sector. It uses gearing, and derivative transactions to mitigate risk and also to enhance returns.

Costs

  • Ongoing charge0.90%
  • Annual management charge -
  • Performance feeYes

Fee structure

The Investment Manager receives a fee equal to 0.65% p.a. of the NAV of Company. The performance fee amounts to 15% of any outperformance of the NAV over the benchmark index. The Company may be terminated by either party giving notice of not less than 12 months.

Value Assessment

  • Value Assessment review date30 March 2025
  • Value Assessment next review date30 March 2026
  • Is Assessment of Value required under COLL?No
  • Outcome of COLL Assessment of Valuen/a
  • Outcome of PRIN Value Assessment or reviewProduct expected to provide fair value for reasonably foreseeable period
  • Other review related to value and or charges -
  • Further information-
Click to see more

Key facts

  • Currency
    GBX
  • Benchmark
    MSCI World Health Care GR
  • Shares in issue
    505.66m
  • Gross gearing
    4.00%
  • EPIC
    WWH
  • ISIN
    GB00BN455J50
  • Domicile
    United Kingdom
  • Exchange
    London Stock Exchange (LON)
  • Index
    FTSE All Share Index, Britain-FTSE250-Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview of the company, currency, shares in issue, EPIC, location, exchange, index, website, Data sourced by LSEG. Objective, Costs, Fee Structure, Key facts including Benchmark, Gross gearing are provided by MorningStar.